10x Genomics, Inc. — Director's Dealing 2025

Feb 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2025-02-24

Reporting Person: Hindson Benjamin J. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-24	Class A Common Stock	S	4573	$11.0656	Disposed	335324	Direct

Footnotes

F1: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.